Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002.

作者信息

Miller Joan W

机构信息

Angiogenesis and Laser Laboratories, Retina Service, Department of Ophtalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2003 Apr;241(4):258-62. doi: 10.1007/s00417-003-0623-y. Epub 2003 Mar 11.

DOI:10.1007/s00417-003-0623-y

PMID:12719985

Abstract

摘要

相似文献

Photodynamic therapy for choroidal neovascularization. The Jules Gonin Lecture, Montreux, Switzerland, 1 September 2002.

Graefes Arch Clin Exp Ophthalmol. 2003 Apr;241(4):258-62. doi: 10.1007/s00417-003-0623-y. Epub 2003 Mar 11.

Photodynamic therapy in patients with idiopathic choroidal neovascularization.

Jpn J Ophthalmol. 2004 Jul-Aug;48(4):422-4. doi: 10.1007/s10384-004-0079-6.

Apparent disappearance of choroidal neovascularization after initial photodynamic therapy with verteporfin.

Arch Ophthalmol. 2002 Nov;120(11):1588-90.

Photodynamic therapy for extrafoveal choroidal neovascularization associated with choroidal nevus.

Retina. 2006 Apr;26(4):477-9. doi: 10.1097/01.iae.0000238543.67003.6a.

Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.光动力疗法治疗眼部弓形虫病继发脉络膜新生血管化

Arch Ophthalmol. 2006 May;124(5):741-3. doi: 10.1001/archopht.124.5.741.

[Photodynamic therapy carefully destroys neovascularization of the retina].光动力疗法可精准破坏视网膜新生血管。

Ophthalmologe. 2003 Feb;100(2):1 p following 174.

Photodynamic therapy for angioid streaks.血管样条纹的光动力疗法。

Ophthalmology. 2007 Aug;114(8):1592. doi: 10.1016/j.ophtha.2007.03.057.

Influence of lesion size on treatment benefit with photodynamic therapy.

Clin Exp Ophthalmol. 2004 Aug;32(4):452-3. doi: 10.1111/j.1442-9071.2004.00860.x.

Verteporfin in Photodynamic Therapy: report no. 5.光动力疗法中的维替泊芬：第5号报告。

Ophthalmology. 2004 Nov;111(11):2144. doi: 10.1016/j.ophtha.2004.08.002.

Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks.维替泊芬光动力疗法治疗并发血管样条纹的脉络膜新生血管。

Ophthalmic Surg Lasers Imaging. 2004 Jan-Feb;35(1):78-80.

引用本文的文献

Verteporfin-induced formation of protein cross-linked oligomers and high molecular weight complexes is mediated by light and leads to cell toxicity.维替泊芬诱导的蛋白交联寡聚物和高分子量复合物的形成是由光介导的，并导致细胞毒性。

Sci Rep. 2017 Apr 21;7:46581. doi: 10.1038/srep46581.

本文引用的文献

Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.玻璃体内注射雷珠单抗联合维替泊芬光动力疗法治疗猴实验性脉络膜新生血管的安全性和有效性

Arch Ophthalmol. 2005 Apr;123(4):509-16. doi: 10.1001/archopht.123.4.509.

Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.脉络膜新生血管大鼠模型中的维替泊芬光动力疗法：血管造影和组织学特征

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2384-91.

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.使用维替泊芬（维速达尔）进行光动力疗法治疗年龄相关性黄斑变性及其他原因引起的脉络膜新生血管的指南。

Retina. 2002 Feb;22(1):6-18. doi: 10.1097/00006982-200202000-00003.

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管：一项随机临床试验的两年结果，该试验纳入隐匿性无典型脉络膜新生血管病变——维替泊芬光动力疗法报告2

Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9.

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.维替泊芬光动力疗法治疗病理性近视性黄斑下脉络膜新生血管。一项随机临床试验的1年结果——VIP报告第1号

Ophthalmology. 2001 May;108(5):841-52. doi: 10.1016/s0161-6420(01)00544-9.

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.维替泊芬光动力疗法治疗年龄相关性黄斑变性中心凹下脉络膜新生血管：两项随机临床试验的两年结果——TAP报告2

Arch Ophthalmol. 2001 Feb;119(2):198-207.

Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells.使用Lu-Tex的光动力疗法在体外诱导细胞凋亡，并且在视网膜毛细血管内皮细胞中血管抑素可增强其效果。

Invest Ophthalmol Vis Sci. 2000 Nov;41(12):3963-71.

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.一项使用维替泊芬进行光动力疗法治疗病理性近视、眼组织胞浆菌病综合征、血管样条纹和特发性病因所致脉络膜新生血管的初步研究。

Arch Ophthalmol. 2000 Mar;118(3):327-36. doi: 10.1001/archopht.118.3.327.

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管：两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法（TAP）研究组

Arch Ophthalmol. 1999 Oct;117(10):1329-45.

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.维替泊芬光动力疗法治疗年龄相关性黄斑变性引起的脉络膜新生血管：1期和2期研究中的再次治疗结果

Arch Ophthalmol. 1999 Sep;117(9):1177-87. doi: 10.1001/archopht.117.9.1177.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验